Home›Stocks›KYNB

KYNB — structural market context

Kyntra Bio, Inc.

Structural market context from public regulatory and market data, shown with its as-of dates. Descriptive only: nothing on this page is a recommendation, a prediction, or advice to buy or sell any security.

What changed

As of the close on Nov 4. Each line shows the earlier value, the later value and their dates.

Price

Change from the Nov 3 close to the Nov 4 close: −8.12%.

Volume

0.85× its 20-session average on Nov 4.

Includes pre- and post-market trading.

Short interest

Short interest 95K shares (settlement Oct 15) vs 100K (Sep 30).

No new file loaded in this window. Latest file: settlement Oct 15, loaded Oct 27.

Analyst rating actions

None recorded in this window.

Insider filings (Form 4)

None recorded in this window.

KYNB events and their magnitude

Latest SEC filing in the event study

8-K 3.01 · Listing compliance notice · filed 2026-10-06 · View on sec.gov ↗

…

How the Event Study works →

KYNB short interest & days to cover

SHARES SHORT

95K

% OF FLOAT

2.7%

DAYS TO COVER

3.5

CHANGE VS PRIOR

-5.0%

FINRA consolidated short interest, reported twice a month and published ~2 weeks after each settlement date. % of float uses reported free float. · as of 2026-10-15 (21d ago)

How short interest and days to cover are measured →

KYNB fails-to-deliver (FTD)

Settlement date	Failed shares	Price
2026-09-08 · 58d	228	$8.55
2026-08-28 · 69d	164	$8
2026-08-26 · 71d	458	$8.1

SEC fails-to-deliver files, published twice a month with ~6 weeks of delay.

How fails-to-deliver are reported →

KYNB analyst ratings

Firm	Action	Rating	Published
Lake Street	initialise	Buy	2026-09-17

Rating actions as published by the firms, from public feeds. They are not graded here.

Frequently asked questions

What is KYNB's short interest?

As of the FINRA settlement date 2026-10-15, KYNB had 95K shares sold short — 2.7% of its float, with 3.5 days to cover at average volume. FINRA publishes this data roughly two weeks after each twice-monthly settlement, so it is inherently delayed. A short-interest figure describes an aggregate position; it does not predict what the stock will do.

What do analysts say about KYNB?

The most recent action: Lake Street initialise to Buy on 2026-09-17. Rating actions are shown as published by the firms; they are not graded here.

Is this page telling me to buy or sell KYNB?

No. Everything on this page is descriptive, structural market context from public data, shown with its as-of dates. TradeAI News does not issue directional recommendations, price predictions, or buy/sell advice — for any ticker.

All covered stocks Short Interest & FTD tracker Insider Buying tracker The platform

Other companies in the same SEC industry: Pharmaceutical Preparations

ACRS · Aclaris Therapeutics, Inc.ALNY · Alnylam Pharmaceuticals, Inc.DYN · Dyne Therapeutics, Inc.KNSA · Kiniksa Pharmaceuticals Intern LQDA · Liquidia Corporation NVS · Novartis AG

Industry: SIC code 2834 as recorded on SEC EDGAR.

All tickers starting with K →

KYNB: the full history

Latest rows shown. Full history, market-wide screens, cluster detection and the context journal live in the dashboard.

Start free →View plans →

Not financial advice. Trading involves risk. Descriptive structural context, never a recommendation.